Dashboard
Manage Tickers

BNOXBIONOMICS LIMITED/FI

Nasdaq bionomics.com.au


$ 0.79 $ -0.05 (-5.5 %)    

Friday, 14-Jun-2024 15:59:55 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 479.30 $ 2.47 (0.52 %)
DIA $ 386.46 $ -0.42 (-0.11 %)
SPY $ 542.65 $ 0.33 (0.06 %)
TLT $ 94.67 $ 0.79 (0.84 %)
GLD $ 215.76 $ 2.76 (1.3 %)
$ 0.78
$ 0.78
$ 0.00 x 0
$ 0.00 x 0
$ 0.78 - $ 0.81
$ 0.65 - $ 6.41
176,048
na
1.16B
$ 0.46
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
06/13/2024 20:31:04

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
06/13/2024 12:07:12

hc-wainwright--co-reiterates-buy-on-bionomics-maintains-8-price-target
HC Wainwright & Co. Reiterates Buy on Bion...
06/12/2024 17:28:34

HC Wainwright & Co. analyst Joseph Pantginis reiterates Bionomics (NASDAQ:BNOX) with a Buy and maintains $8 price target.

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
05/31/2024 12:06:22

bionomics-limited-private-placement-of-adss-with-institutional-investor-for-total-gross-proceeds-of-up-to-70m
Bionomics Limited Private Placement Of ADS...
05/31/2024 12:01:59

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
05/21/2024 16:31:03

12-health-care-stocks-moving-in-tuesdays-after-market-session
12 Health Care Stocks Moving In Tuesday's ...
04/02/2024 20:31:04

hc-wainwright--co-reiterates-buy-on-bionomics-maintains-8-price-target
HC Wainwright & Co. Reiterates Buy on Bion...
03/21/2024 16:02:41

HC Wainwright & Co. analyst Joseph Pantginis reiterates Bionomics (NASDAQ:BNOX) with a Buy and maintains $8 price target.

bionomics-reveals-detailed-data-from-ptsd-trial-stock-soars
Bionomics Reveals Detailed Data From PTSD ...
03/21/2024 13:36:01

Bionomics' Phase 2b ATTUNE trial on BNC210 for PTSD. Discover statistically significant improvements in symptom severity, c...

bionomics-shares-are-trading-higher-after-the-company-disclosed-results-of-phase-2b-attune-trial-of-bnc210-in-post-traumatic-stress-disorder
Bionomics shares are trading higher after ...
03/21/2024 10:09:42

bionomics-disclosed-results-of-the-full-dataset-analysis-from-attune-phase-2b-trial-of-bnc210-in-patients-with-post-traumatic-stress-disorder
Bionomics Disclosed Results Of The Full Da...
03/21/2024 10:04:36

12-health-care-stocks-moving-in-mondays-pre-market-session
12 Health Care Stocks Moving In Monday's P...
01/22/2024 13:05:58

bionomics-provided-a-2023-review-and-its-outlook-for-2024
Bionomics Provided A 2023 Review And Its O...
01/22/2024 11:04:54

Positive Phase 2b data announced for BNC210 on reduction of total symptom severity and multiple symptom clusters in post-trau...

hc-wainwright--co-reiterates-buy-on-bionomics-maintains-8-price-target
HC Wainwright & Co. Reiterates Buy on Bion...
12/07/2023 11:38:19

HC Wainwright & Co. analyst Joseph Pantginis reiterates Bionomics (NASDAQ:BNOX) with a Buy and maintains $8 price target.

12-health-care-stocks-moving-in-wednesdays-after-market-session
12 Health Care Stocks Moving In Wednesday'...
12/06/2023 21:31:12

bionomics-presents-detailed-data-on-the-validity-and-reliability-of-the-subjective-units-of-distress-scale-at-the-2023-american-college-of-neuropsychopharmacology-annual-meeting
Bionomics Presents Detailed Data On The Va...
12/06/2023 13:09:34

A psychometric analysis concluded that Subjective Units of Distress Scale (SUDS) is a psychometrically valid, sensitive, and re...

bionomics-has-been-granted-european-patent-ep3867252-titled-6-indan-2-yloxy-3-morpholine-4-carbonyl-18-naphthyridin-4-one-derivatives--similar-compounds-as-modulators-of-the-alpha-7-nicotinic-acetylcholine-receptor-for-the-treatment-of-anxiety
Bionomics Has Been Granted European Patent...
11/03/2023 17:41:36

https://register.epo.org/application?number=EP19873627

bionomics-meets-the-fda-lead-drug-candidate-for-social-anxiety-heads-to-phase-3
Bionomics Meets The FDA: Lead Drug Candida...
10/18/2023 02:28:01

Biopharma company Bionomics Ltd.

bionomics-announced-the-outcomes-of-an-end-of-phase-2-meeting-with-the-fda-for-bnc210-for-the-acute-treatment-of-social-anxiety-disorder-into-phase-3-studies-first-patient-dosing-in-phase-3-program-planed-for-q1-fy24---8k
Bionomics Announced The Outcomes Of An End...
10/16/2023 10:55:18

https://www.benzinga.com/secfilings/23/10/35261568/bionomics-limitedfi-general-corporate-statement-by-foreign-issuer-form6

psyched-steve-cohens-new-biopharma-bet-california-gov-authorizes-medical-psychedelics--more
Psyched: Steve Cohen's New Biopharma Bet, ...
10/06/2023 21:07:21

Steve Cohen Keeps Betting On Biopharma With Purchase Of 119M+ Bionomics Shares

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

06/28/2024 Malibu Boats, Inc. (MBUU)
07/01/2024 Globe Life Inc. f/k/a Torchmark Corporation (GL)
07/01/2024 Equinix, Inc. (EQIX)
07/02/2024 Intel Corporation (INTC)
07/05/2024 AXT, Inc. (AXTI)
07/05/2024 Altimmune, Inc. (ALT)
07/09/2024 Li Auto Inc. (LI)
07/12/2024 Inari Medical, Inc. (NARI)
07/12/2024 Sprout Social, Inc. (SPT)
07/15/2024 UnitedHealth Group Inc. (UNH)

NEW CASE INVESTIGATION

AnaptysBio Inc (ANAB)